Amneal Pharmaceuticals, Inc. (AMRX)

USD 7.69

(-4.71%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.47 Billion 3.79 Billion 3.93 Billion 4 Billion 3.66 Billion 4.35 Billion
Total Current Assets 1.37 Billion 1.41 Billion 1.52 Billion 1.55 Billion 1.21 Billion 1.28 Billion
Cash And Short Term Investments 91.54 Million 25.97 Million 247.79 Million 341.37 Million 151.19 Million 213.39 Million
Cash and Cash Equivalents 91.54 Million 25.97 Million 247.79 Million 341.37 Million 151.19 Million 213.39 Million
Short Term Investments 2.2 Million 1.82 Million 1.17 Million 1.69 Million 1.12 Million 2.14 Million
Net Receivables 645.66 Million 742.29 Million 663.76 Million 640.3 Million 606.15 Million 482.32 Million
Inventory 581.38 Million 530.73 Million 489.38 Million 490.64 Million 381.06 Million 457.21 Million
Other Current Assets 91.2 Million 103.56 Million 110.21 Million 73.46 Million 70.16 Million 128.32 Million
Total Non-Current Assets 2.09 Billion 2.38 Billion 2.41 Billion 2.45 Billion 2.45 Billion 3.06 Billion
Net PPE 550.13 Million 589.36 Million 639 Million 595.16 Million 609.15 Million 544.14 Million
Good Will And Intangible Assets 1.48 Billion 1.69 Billion 1.75 Billion 1.82 Billion 1.8 Billion 2.08 Billion
Good Will 598.62 Million 598.85 Million 593.01 Million 522.81 Million 419.5 Million 426.22 Million
Intangible Assets 890.42 Million 1.09 Billion 1.16 Billion 1.3 Billion 1.38 Billion 1.65 Billion
Long-Term Investments 37.08 Million 85.58 Million - - 16.37 Million -
Tax Assets -37.08 Million -85.58 Million - - -16.37 Million 373.15 Million
Other Non Current Assets 55.51 Million 103.21 Million 20.61 Million 31.88 Million 44.27 Million 67.59 Million
Other Assets - - - - - -
Total Liabilities 3.45 Billion 3.59 Billion 3.57 Billion 3.66 Billion 3.31 Billion 3.45 Billion
Total Current Liabilities 846.59 Million 752.8 Million 677.24 Million 676.9 Million 550.4 Million 553.85 Million
Account Payables 143.57 Million 538.19 Million 583.34 Million 613.66 Million 507.48 Million 514.44 Million
Tax Payables - 359 Thousand 2.52 Million 5.53 Million 8.72 Million -
Short Term Debt 227.62 Million 104.63 Million 46.03 Million 55.68 Million 36.95 Million 21.71 Million
Deferred Revenue 398.41 Million - - - - 17.42 Million
Other Current Liabilities 76.98 Million 109.96 Million 47.86 Million 7.56 Million 5.96 Million 266 Thousand
Total Non Current Liabilities 2.6 Billion 2.83 Billion 2.89 Billion 2.98 Billion 2.76 Billion 2.9 Billion
Long-Term Debt 2.52 Billion 2.74 Billion 2.83 Billion 2.88 Billion 2.72 Billion 2.66 Billion
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 83.06 Million 97.11 Million 65.42 Million 99.07 Million 39.58 Million 231.66 Million
Other Liabilities - - - - - -
Total Equity 20.01 Million 208.92 Million 373.6 Million 386.59 Million 461.56 Million 1.28 Billion
Stock Holders Equity 19.78 Million 183.97 Million 366.97 Million 344.93 Million 346.78 Million 896.36 Million
Common Stock 3.06 Million 3.03 Million 3.01 Million 2.99 Million 2.99 Million 2.98 Million
Retained Earnings -490.17 Million -406.18 Million -276.19 Million -286.82 Million -377.88 Million -20.92 Million
Accumulated other comprehensive income -32.34 Million 9.93 Million -24.82 Million -41.31 Million -68 Thousand -7.75 Million
Common Stock Equity 19.78 Million 183.97 Million 366.97 Million 344.93 Million 346.78 Million 896.36 Million
Capital Lease Obligation 109.94 Million 123.48 Million 127.35 Million 123.87 Million 135.54 Million 39.34 Million
Total Investments 39.28 Million 87.4 Million 1.17 Million 1.69 Million 17.49 Million 2.14 Million
Total Debt 2.75 Billion 2.84 Billion 2.87 Billion 2.94 Billion 2.76 Billion 2.69 Billion
Net Debt 2.65 Billion 2.81 Billion 2.62 Billion 2.59 Billion 2.61 Billion 2.47 Billion

Balance Sheet Charts